174 related articles for article (PubMed ID: 10197640)
1. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin.
Ellerbroek SM; Fishman DA; Kearns AS; Bafetti LM; Stack MS
Cancer Res; 1999 Apr; 59(7):1635-41. PubMed ID: 10197640
[TBL] [Abstract][Full Text] [Related]
2. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.
Ellerbroek SM; Wu YI; Overall CM; Stack MS
J Biol Chem; 2001 Jul; 276(27):24833-42. PubMed ID: 11331272
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
4. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
Fishman DA; Bafetti LM; Stack MS
Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
6. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
Fishman DA; Liu Y; Ellerbroek SM; Stack MS
Cancer Res; 2001 Apr; 61(7):3194-9. PubMed ID: 11306508
[TBL] [Abstract][Full Text] [Related]
8. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis.
Siu MK; Cheng CY
Biol Reprod; 2004 Apr; 70(4):945-64. PubMed ID: 14645107
[TBL] [Abstract][Full Text] [Related]
9. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
[TBL] [Abstract][Full Text] [Related]
11. Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins.
Zigrino P; Drescher C; Mauch C
Eur J Cell Biol; 2001 Jan; 80(1):68-77. PubMed ID: 11211937
[TBL] [Abstract][Full Text] [Related]
12. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells.
Wang DR; Sato M; Li LN; Miura M; Kojima N; Senoo H
Cell Struct Funct; 2003 Dec; 28(6):505-13. PubMed ID: 15004420
[TBL] [Abstract][Full Text] [Related]
14. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
Deryugina EI; Bourdon MA; Jungwirth K; Smith JW; Strongin AY
Int J Cancer; 2000 Apr; 86(1):15-23. PubMed ID: 10728589
[TBL] [Abstract][Full Text] [Related]
15. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
Caenazzo C; Onisto M; Sartor L; Scalerta R; Giraldo A; Nitti D; Garbisa S
Clin Cancer Res; 1998 Sep; 4(9):2179-86. PubMed ID: 9748137
[TBL] [Abstract][Full Text] [Related]
16. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
17. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
18. The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis.
Graesser D; Mahooti S; Haas T; Davis S; Clark RB; Madri JA
Lab Invest; 1998 Nov; 78(11):1445-58. PubMed ID: 9840619
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
[TBL] [Abstract][Full Text] [Related]
20. Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells.
Baciu PC; Suleiman EA; Deryugina EI; Strongin AY
Exp Cell Res; 2003 Nov; 291(1):167-75. PubMed ID: 14597417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
